Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$111.15 - $128.97 $3.93 Million - $4.57 Million
-35,400 Reduced 42.14%
48,600 $5.52 Million
Q2 2024

Aug 01, 2024

SELL
$123.8 - $132.96 $16.9 Million - $18.2 Million
-136,700 Reduced 61.94%
84,000 $10.4 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $2.45 Million - $2.85 Million
21,600 Added 10.85%
220,700 $29.1 Million
Q4 2023

Feb 01, 2024

BUY
$100.18 - $109.02 $7.72 Million - $8.41 Million
77,100 Added 63.2%
199,100 $21.7 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $2.04 Million - $2.26 Million
19,800 Added 19.37%
122,000 $12.6 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $37.7 Million - $41.1 Million
-347,400 Reduced 77.27%
102,200 $11.8 Million
Q1 2023

May 08, 2023

BUY
$102.94 - $114.86 $12.9 Million - $14.4 Million
125,400 Added 38.68%
449,600 $47.8 Million
Q4 2022

Feb 01, 2023

BUY
$87.44 - $112.11 $11.7 Million - $15 Million
133,500 Added 70.01%
324,200 $36 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $9.15 Million - $10.3 Million
108,200 Added 131.15%
190,700 $16.4 Million
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $6.89 Million - $7.81 Million
82,500 New
82,500 $7.52 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $751,464 - $857,088
-10,800 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $2.5 Million - $2.93 Million
-49,100 Reduced 81.97%
10,800 $655,000
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $5.84 Million - $6.79 Million
-114,600 Reduced 65.67%
59,900 $3.26 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $2.44 Million - $2.91 Million
47,200 Added 37.08%
174,500 $9.82 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $4.1 Million - $4.41 Million
-69,900 Reduced 35.45%
127,300 $8.15 Million
Q2 2017

Aug 14, 2017

BUY
N/A
197,200
197,200 $12.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.